Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05312008 · ClinicalTrials.gov registry record · Phase 2
Does Oxytocin Alter Tolerance to or Motivation for Alcohol
A Phase 2 study, sponsored by Indiana University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT05312008 is a Phase 2 study that was terminated before completion, run by Indiana University. The registered enrollment target is 6 participants.
The verdict
NCT05312008, a Phase 2 study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
This pilot study is intended to demonstrate feasibility and acquire preliminary data. If successful, this data could support a future project studying the effect of oxytocin on tolerance and alcohol seeking in humans.
Interventions
- DRUG Intranasal oxytocin
- DRUG Intranasal placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2022-01-16 |
| Est. Completion | 2023-12-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05312008
The ClinicalTrials.gov registry entry for NCT05312008 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intranasal oxytocin is the first listed.
NCT05312008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05312008 about?
NCT05312008 is a clinical study titled "Does Oxytocin Alter Tolerance to or Motivation for Alcohol". This pilot study is intended to demonstrate feasibility and acquire preliminary data. If successful, this data could support a future project studying the effect of oxytocin on tolerance and alcohol seeking in humans.
What is the current status of trial NCT05312008?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2022-01-16. Estimated completion is 2023-12-21.
What interventions are being tested in trial NCT05312008?
The interventions under investigation include: Intranasal oxytocin (DRUG), Intranasal placebo (DRUG).
Who is sponsoring clinical trial NCT05312008?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.